Re: Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction Bacillus Calmette-Guerin therapy

被引：1
|
作者：
Krajewski, Wojciech [1 ]
Zdrojowy, Romuald [1 ]
Kolodziej, Anna [1 ]
机构：
[1] Wroclaw Med Univ, Dept Urol & Oncol Urol, Wroclaw, Poland
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2019年 / 37卷 / 06期
关键词：
Nonmuscle-invasive bladder cancer; Bacillus Calmette-Guerin; Recurrence; Progression; Purified protein derivative skin test;
D O I：
10.1016/j.urolonc.2019.01.024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：346 / 347
页数：2
相关论文
共 50 条
  • [31] The Effect of Restaging Transurethral Resection on Recurrence and Progression Rates in Patients with Nonmuscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
    Sfakianos, John P.
    Kim, Philip H.
    Hakimi, A. Ari
    Herr, Harry W.
    JOURNAL OF UROLOGY, 2014, 191 (02): : 341 - 345
  • [32] A Prospective Comparative Study of Intravesical Bacillus Calmette-Guerin Therapy with the Tokyo or Connaught Strain for Nonmuscle Invasive Bladder Cancer
    Sengiku, Atsushi
    Ito, Masaaki
    Miyazaki, Yu
    Sawazaki, Harutake
    Takahashi, Takeshi
    Ogura, Keiji
    JOURNAL OF UROLOGY, 2013, 190 (01): : 50 - 54
  • [33] THE CLINICAL IMPACT OF INDURATION RESULTING FROM PURIFIED PROTEIN DEPRIVATION SKIN TEST IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH BACILLUS-CALMETTE GUERIN
    Niwa, Naoya
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Kosaka, Takeo
    Mizuno, Ryuichi
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1230 - E1230
  • [34] Intravesical Immunomodulatory Imiquimod Enhances Bacillus Calmette-Guerin Downregulation of Nonmuscle-invasive Bladder Cancer
    Camargo, Juliana A.
    Passos, Gabriela R.
    Ferrari, Karen L.
    Billis, Athanase
    Saad, Mario J. A.
    Reis, Leonardo O.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : E587 - E593
  • [35] Endovesical Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in Kidney Transplant Recipients: Is It Safe and Efficacious?
    Prudhomme, Thomas
    Andras, Iulia
    Boissier, Romain
    Campi, Riccardo
    Hevia, Vital
    Territo, Angelo
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (08) : 789 - 791
  • [36] Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guerin therapy
    Mengual, Lourdes
    Marin-Aguilera, Mercedes
    Ribal, Maria Jose
    Burset, Moises
    Villavicencio, Humberto
    Oliver, Artur
    Alcaraz, Antonio
    EUROPEAN UROLOGY, 2007, 52 (03) : 752 - 759
  • [37] Long-Term Survival Outcomes with Intravesical Docetaxel for Recurrent Nonmuscle Invasive Bladder Cancer After Previous Bacillus Calmette-Guerin Therapy
    Barlow, LaMont J.
    McKiernan, James M.
    Benson, Mitchell C.
    JOURNAL OF UROLOGY, 2013, 189 (03): : 834 - 839
  • [38] EXTERNAL VALIDATION OF EORTC AND CUETO SCORING MODELS TO PREDICT RECURRENCE AND PROGRESSION IN PATIENTS WITH NONMUSCLE INVASIVE BLADDER CANCER TREATED WITH BACILLUS CALMETTE-GUERIN
    Kohjimoto, Yasuo
    Kusumoto, Hiroki
    Matsumura, Nagahide
    Inagaki, Takeshi
    Hara, Isao
    JOURNAL OF UROLOGY, 2012, 187 (04): : E716 - E717
  • [39] Does switching the bacillus Calmette-Guerin strain affect clinical outcome in patients with recurrent non muscle-invasive bladder cancer after initial bacillus Calmette-Guerin therapy?
    Niwa, Naoya
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Kosaka, Takeo
    Mizuno, Ryuichi
    Oya, Mototsugu
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 306.e1 - 306.e8
  • [40] Diminished Efficacy of Bacille Calmette-Guerin Among Elderly Patients with Nonmuscle Invasive Bladder Cancer
    Margel, David
    Alkhateeb, Sultan S.
    Finelli, Antonio
    Fleshner, Neil
    UROLOGY, 2011, 78 (04) : 848 - 854
12345